10.12.2012 Views

netLibrary - eBook Summary Structure-based Drug Design by ...

netLibrary - eBook Summary Structure-based Drug Design by ...

netLibrary - eBook Summary Structure-based Drug Design by ...

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Document<br />

Page 306<br />

monitored <strong>by</strong> NMR, was unchanged, although it should be noted that the structure of the loop containing<br />

Arg14 was not well defined in either native or trypsinised AP-A. That the backbone structure was<br />

largely unaffected was confirmed <strong>by</strong> the observation that the NH and CαH chemical shifts were<br />

unaltered except in the immediate vicinity of the cleavage (which is the site of a reverse turn in AP-A<br />

[46]) and the N-terminal regions of the loop and the second strand of the sheet. It is possible that<br />

perturbations of functionally important groups near the start of the loop may be responsible for the lack<br />

of activity of the trypsinised derivative, and now that a high-resolution structure is available for AP-A a<br />

more detailed comparison with the cleavage product would be useful. Other possible explanations for<br />

the lack of activity are that the position of the Arg14 side chain relative to other key residues in the<br />

molecule is more important than suggested <strong>by</strong> chemical modification and site-directed mutagenesis data,<br />

or that the introduction of additional charges associated with the new termini affects activity.<br />

Endoproteinase LysC cleaved AP-A between Lys37 and Ala38 to yield a derivative with cardiotonic<br />

activity an order of magnitude lower than that of the parent molecule (Monks SA and Norton RS,<br />

unpublished results). This reduction in activity could be a consequence of local conformational<br />

perturbations. Treatment of AP-B with carboxypeptidase B removed Lys49, resulting in only a two-fold<br />

reduction in cardiotonic activity (Monks SA and Norton RS, unpublished results).<br />

C. Sequence Comparisons<br />

Among the Type 1 toxins shown in Figure 2, the Bc and Bg toxins (from the genus Bunodosuma) form a<br />

subgroup with characteristic differences from the Anemonia and Anthopleura toxins at residues 5, 12–13<br />

and 37–42. In addition, the Bg toxins also have Asp7 rarrow.gif Lys and Gly27 rarrow.gif Arg<br />

substitutions. A potent toxin in mice [26], the cardiac stimulatory activity of Bg II has not been reported.<br />

The potent activity of Bg II was ascribed to its abundance of positive charges [26]. Ignoring the<br />

histidines, which at least in AP-A and ATX II would be predominantly in their neutral forms at<br />

physiological pH [57], Bg II has six positively charged side chains and only one negatively charged side<br />

chain, whereas, AP-A has three and two respectively, and AP-B has five and two. As discussed below,<br />

however, it may be that an abundance of positive charge is associated with a lack of discrimination<br />

between the neuronal and cardiac sodium channels, as found for the scorpion α-toxins.<br />

Comparison of the activities of Af I and Af II is useful because of their close similarity. Differences<br />

between Af I and Af II are Ala3 rarrow.gif Pro, Asn12 rarrow.gif Ser, Thr21 rarrow.gif Ile, and an<br />

additional Gly at the N-terminus. Inspection of the sequences in Figures 2 shows that the identity of<br />

residue 3 correlates with that of residue 21, Ala or Ser at 3 co-occurring with Thr21, and Pro 3 with<br />

Ile21<br />

http://legacy.netlibrary.com/nlreader/nlReader.dll?bookid=12640&filename=Page_306.html [4/5/2004 5:23:44 PM]

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!